Diabetic Peripheral Neuropathy: Introducing New Interventional Options

Diabetes can impact nearly every cell in the patient, damaging the cardiovascular and nervous systems. Among the 10% of Americans who suffer from diabetes, as many as 4 million experience chronic pain due to diabetic peripheral neuropathy (DPN). Medical management of painful DPN has been challenged by dose limiting side effects and cost. This presentation will review the pathophysiology of painful DPN and treatment options. We will describe innovations such as high frequency spinal cord stimulation therapy for use by both noninterventional and interventional pain physicians and topical capsaicin patch therapy. Finally, we will propose a multidisciplinary model of treating DPN that includes existing and emerging therapies.

Learning Objectives

  • Discuss the pathophysiology of diabetic peripheral neuropathy (DPN)
  • Review clinical presentation of DPN
  • Define painful diabetic neuropathy (PDN)
  • Explore current and new treatment continuum of PDN
  • Review body of evidence supporting new PDN treatments

Additional Information

Partner: 
Tarsus Medical Education
State Relevance: 
Georgia Requirement
Kansas Requirement
Michigan Requirement
Nevada Requirement
Oklahoma Requirement
Texas Requirement
Vermont Requirement
Washington Requirement
Course summary
Available credit: 
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
11/01/2021
Course expires: 
11/01/2022
Rating: 
0

Sean Li

MD Adjunct Clinical Associate Professor

Rutgers New Jersey Medical School Newark, NJ

Regional Medical Director

Premier Pain Centers

Affiliate of National Spine and Pain Centers Shrewsbury, NJ

Disclosure

  • Consulting Fee (e.g., Advisory Board): Abbott, Avanos, Biotronik, Boston Scientific, Gruenthal, Nalu, Nevro, PainTeq, Saluda, SI Bone, SPR Therapeutics, Vertos
  • Contracted Research (Principal Investigators must provide information, even if received by the institution): Avanos, Biotronik, Boston Scientific, Nalu, Nevro, PainTeq, Saluda, SPR Therapeutics
  • Stock Shareholder (Individual stocks/Stock options; diversified mutual funds do not need to be disclosed): Nalu, National Spine and Pain Centers

Available Credit

  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.

Mocingbird members get an additional 10% discount on all Tarsus Medical Education - Pain Week courses. Use the discount code "MOC10" to claim the additional 10% discount before you check out from your cart.

To take this course you will be redirected to Tarsus Medical Education's website. Simply create a free account with Tarsus Medical Education in order to complete this activity. You can even use your same Mocingbird username and password to create the account.

Mocingbird is pleased to provide our members with discounted access to highly respected and awarded educational partners.

Topics

Pain Management,